We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCVH.L Regulatory News (CVH)

  • There is currently no data for CVH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8 (OPD) - Cavanagh Group PLC

3 Feb 2011 13:51

RNS Number : 6512A
Cavanagh Group PLC
03 February 2011
 



FORM 8 (OPD)

 

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Identity of the party to the offer making the disclosure:

Cavanagh Group plc

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each party to the offer

Cavanagh Group plc

(d) Is the party to the offer making the disclosure the offeror or the offeree?

OFFEREE

(e) Date position held:

2 February 2011

(f) Has the party previously disclosed, or is it today disclosing, under the Code in respect of any other party to this offer?

NO

 

2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

 

Class of relevant security:

 

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

NIL

NIL

(2) Derivatives (other than options):

NIL

NIL

(3) Options and agreements to purchase/sell:

NIL

NIL

 

TOTAL:

NIL

NIL

 

All interests and all short positions should be disclosed.

 

Details of any open derivative or option positions, or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

(b) Rights to subscribe for new securities

 

Class of relevant security in relation to which subscription right exists:

NIL

Details, including nature of the rights concerned and relevant percentages:

N/A

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(c) Irrevocable commitments and letters of intent

 

Details of any irrevocable commitments or letters of intent procured by the party to the offer making the disclosure or any person acting in concert with it (see Note 3 on Rule 2.11 of the Code):

 

None

 

 

3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

Details of any interests, short positions and rights to subscribe of any person acting in concert with the party to the offer making the disclosure:

 

 

Name

Beneficial interest in Cavanagh shares

% of issues share capital

Andrew Fay

2,619,394

22.59%

Simon Redgrove

2,536,859

21.88%

Neill Millard

1,804,899

15.56%

Paul Hogarth

703,118

6.07%

Charles Gillespie

286,690

2.47%

Ian Henson

244,802

2.11%

Paul Sinnett

110,000

0.95%

Kenneth Timmins

27,775

0.24%

 

 

In addition, the following directors hold awards granted under the Cavanagh's share option scheme:

 

Name

Interest in Cavanagh shares

Vesting Date

Paul Sinnett

20,588

9 October 2006 - 8 October 2013

Kenneth Timmins

18,518

2 January 2007 - 1 January 2014

Charles Gillespie

18,518

2 January 2007 - 1 January 2014

Ian Henson

83,000

6 December 2008 - 5 December 2015

 

 

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3 for each additional class of relevant security.

 

Details of any open derivative or option positions, or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(c) Attachments

 

Are any Supplemental Forms attached?

 

Supplemental Form 8 (Open Positions)

NO

Supplemental Form 8 (SBL)

NO

 

 

Date of disclosure:

3 February 2011

Contact name:

Andrew Fay

Telephone number:

01444 475425

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FEEUOVORARAURAR
Date   Source Headline
13th Nov 20237:00 amRNS3rd Quarter and 9 Month Results
6th Nov 20233:10 pmRNSExpected Delisting of Global Depositary Shares
11th Aug 20237:28 amRNSFirst Half and Second Quarter 2023 Results
11th May 20238:16 amRNS1st Quarter Results
4th May 202310:16 amRNSPayment of Dividends in kind
4th May 202310:15 amRNSAudit Committee
2nd May 20237:00 amRNSDirectorate Information
2nd May 20237:00 amRNSAGM Statement
2nd May 20237:00 amRNSAnnual Financial Report
20th Apr 20238:01 amRNSCNV Approves Subsidiary Merger Prospectus
14th Apr 20237:00 amRNSResponse to Shareholder Information Request
23rd Mar 20233:00 pmRNSCVH Calls Annual Shareholders’ Meeting
14th Mar 202311:11 amRNSLeave of Absence
13th Mar 20234:56 pmRNSFull Year and Last Quarter 2022 Results
13th Mar 20237:00 amRNSBoard of Directors Approves Subsidiary Merger
6th Mar 20237:00 amRNSWebcast to discuss 4Q and FY 2022 results
20th Feb 20237:00 amRNSComposition of Audit Committee
16th Jan 20236:15 pmRNSSecretary of Trade imposes Fine on Subsidiary
7th Dec 20227:00 amRNSDirectorate Change
7th Dec 20227:00 amRNSClass “A” Shareholders’ Meeting
23rd Nov 20226:21 pmRNSNotice of Class "A" Shareholders' Meeting
23rd Nov 20226:19 pmRNSPresident of the Board Tenders Resignation
18th Nov 20227:28 amRNSPresident of the Board Tenders Resignation
11th Nov 20227:57 amRNSNine months and Third Quarter 2022 Results
31st Oct 20228:07 amRNSNotice of Results
11th Aug 20227:32 amRNSFirst Half and Second Quarter 2022 Results
25th Jul 20226:21 pmRNSNotice of Results
12th Jul 20227:48 amRNSPayment of Dividends in Kind
11th Jul 20229:02 amRNSAnnual Shareholders’ Meeting
11th Jul 20228:58 amRNSPayment of Dividends in Kind
5th Jul 20223:03 pmRNSAmended and Restated Deposit Agreement
5th Jul 20221:03 pmRNSResponse to Shareholder information Request
23rd Jun 20227:29 amRNSResponse to Shareholder Information Request
6th Jun 20227:00 amRNSBoard Calls Extraordinary Shareholders' Meeting
12th May 20227:00 amRNS1st Quarter 2022 Results
4th May 20227:50 amRNSMembership of Audit Committee
3rd May 20227:00 amRNSWebcast presentation to discuss 1Q 2022 results
29th Apr 20228:23 amRNSList of the Company Authorities
29th Apr 20228:19 amRNSAGM Statement
14th Apr 20227:00 amRNSResponse to Shareholder Information Request
14th Apr 20227:00 amRNSResignation of Member of Supervisory Committee
18th Mar 20221:05 pmRNSCVH Calls Annual Shareholders' Meeting
16th Mar 20227:04 amRNSAppointment of alternate market relations officer
11th Mar 20228:56 amRNSFull Year and Last Quarter 2021 Results
18th Feb 20228:40 amRNSSupreme Court dismisses Government Appeal
10th Nov 20217:50 amRNSNine months and Third Quarter 2021 Results
2nd Sep 202111:44 amRNSCVH Announces Payment of Dividends in Kind
2nd Sep 202111:24 amRNSCVH announces payments of dividends in kind
2nd Sep 202111:22 amRNSCVH Holds Extraordinary Shareholders Meeting
23rd Aug 20217:00 amRNSDirector/PDMR Shareholding - Replacement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.